Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Neurology
|
February 21, 2007
A secondary progressive clinical course is uncommon in neuromyelitis optica
D M Wingerchuk, S J Pittock, C F Lucchinetti, et al.
Neurology
|
August 1, 1997
Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
B G Weinshenker, D M Wingerchuk, Q Liu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 30, 2010
A window of opportunity for no treatment in early multiple sclerosis?
C P Gilmore, D A Cottrell, N J Scolding, et al.
Neurology
|
May 5, 1999
Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS
B G Weinshenker, D Hebrink, D M Wingerchuk, et al.
Neurology
|
April 25, 2008
NMO-IgG predicts the outcome of recurrent optic neuritis
M Matiello, V A Lennon, A Jacob, et al.
Neurology
|
June 27, 2002
Is there a neurologist on this flight?
J I Sirven, D W Claypool, K L Sahs, et al.
Neurology
|
April 13, 2005
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
D M Wingerchuk, E E Benarroch, P C O'Brien, et al.
Brain : a Journal of Neurology
|
February 25, 2000
The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis
G C Ebers, W J Koopman, W Hader, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
AQP4 autoantibody assay performance in clinical laboratory service
J P Fryer, V A Lennon, S J Pittock, et al.
Neurology
|
June 13, 2001
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis
J H Noseworthy, P C O'Brien, T M Petterson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Neurology
|
February 21, 2007
A secondary progressive clinical course is uncommon in neuromyelitis optica
D M Wingerchuk, S J Pittock, C F Lucchinetti, et al.
Neurology
|
August 1, 1997
Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis
B G Weinshenker, D M Wingerchuk, Q Liu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 30, 2010
A window of opportunity for no treatment in early multiple sclerosis?
C P Gilmore, D A Cottrell, N J Scolding, et al.
Neurology
|
May 5, 1999
Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS
B G Weinshenker, D Hebrink, D M Wingerchuk, et al.
Neurology
|
April 25, 2008
NMO-IgG predicts the outcome of recurrent optic neuritis
M Matiello, V A Lennon, A Jacob, et al.
Neurology
|
June 27, 2002
Is there a neurologist on this flight?
J I Sirven, D W Claypool, K L Sahs, et al.
Neurology
|
April 13, 2005
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
D M Wingerchuk, E E Benarroch, P C O'Brien, et al.
Brain : a Journal of Neurology
|
February 25, 2000
The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis
G C Ebers, W J Koopman, W Hader, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
AQP4 autoantibody assay performance in clinical laboratory service
J P Fryer, V A Lennon, S J Pittock, et al.
Neurology
|
June 13, 2001
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis
J H Noseworthy, P C O'Brien, T M Petterson, et al.
Page
of 4